Furthermore, SREBP2 interacts with transcription factor CP2 (TFCP2) in pancreatic cancer cells, allowing them to overcome KRAS mutation-induced senescence (Zhang D. et al., 2021). This evidence concerns the gene SREBF2 and familial pancreatic carcinoma.